Healthcare provider profile · identity verified

John E. Conwell, MD

Family Practice · LITITZ, PA · NPI 1457397614

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	258	73
Lisinopril	Lisinopril	258	63
Levothyroxine Sodium	Levothyroxine Sodium	251	58
Losartan Potassium	Losartan Potassium	250	64
Omeprazole	Omeprazole	240	69
Oxycodone Hcl	Oxycodone Hcl	193	33
Simvastatin	Simvastatin	189	48
Gabapentin	Gabapentin	155	53
Amlodipine Besylate	Amlodipine Besylate	153	40
Metformin Hcl	Metformin Hcl	148	41
Metoprolol Succinate	Metoprolol Succinate	146	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	135	39
Tamsulosin Hcl	Tamsulosin Hcl	125	32
Sertraline Hcl	Sertraline Hcl	119	30
Rosuvastatin Calcium	Rosuvastatin Calcium	111	31
Pantoprazole Sodium	Pantoprazole Sodium	108	25
Hydrochlorothiazide	Hydrochlorothiazide	100	25
Albuterol Sulfate Hfa	Albuterol Sulfate	97	36
Fluticasone Propionate	Fluticasone Propionate	89	29
Januvia	Sitagliptin Phosphate	86	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	28
Famotidine	Famotidine	80	25
Furosemide	Furosemide	78	27
Lorazepam	Lorazepam	77	25
Zolpidem Tartrate	Zolpidem Tartrate	73	19
Jardiance	Empagliflozin	72	17
Clopidogrel	Clopidogrel Bisulfate	71	18
Pravastatin Sodium	Pravastatin Sodium	69	16
Diclofenac Sodium	Diclofenac Sodium	68	14
Escitalopram Oxalate	Escitalopram Oxalate	68	20
Venlafaxine Hcl Er	Venlafaxine Hcl	67	13
Trazodone Hcl	Trazodone Hcl	66	14
Alprazolam	Alprazolam	65	20
Prednisone	Prednisone	63	47
Morphine Sulfate Er	Morphine Sulfate	62	12
Tramadol Hcl	Tramadol Hcl	62	26
Eliquis	Apixaban	60	16
Amoxicillin	Amoxicillin	59	40
Glipizide	Glipizide	56	18
Metoprolol Tartrate	Metoprolol Tartrate	56	16
Pregabalin	Pregabalin	50	13
Diazepam	Diazepam	49	13
Montelukast Sodium	Montelukast Sodium	48	13
Doxycycline Hyclate	Doxycycline Hyclate	46	39
Bupropion Xl	Bupropion Hcl	45	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Olmesartan Medoxomil	Olmesartan Medoxomil	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	11
Synthroid	Levothyroxine Sodium	43	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	20
Finasteride	Finasteride	41	13
Ropinirole Hcl	Ropinirole Hcl	41	11
Xarelto	Rivaroxaban	41	suppressed
Potassium Chloride	Potassium Chloride	40	12
Linzess	Linaclotide	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	35
Baclofen	Baclofen	35	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Metformin Hcl Er	Metformin Hcl	33	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Glipizide Er	Glipizide	32	suppressed
Fentanyl	Fentanyl	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Oxycontin	Oxycodone Hcl	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	suppressed
Atenolol	Atenolol	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Clonazepam	Clonazepam	26	11
Entresto	Sacubitril/Valsartan	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Naproxen	Naproxen	24	suppressed
Ozempic	Semaglutide	24	suppressed
Torsemide	Torsemide	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Azithromycin	Azithromycin	21	16
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Cefuroxime	Cefuroxime Axetil	19	17
Cephalexin	Cephalexin	19	14
Glimepiride	Glimepiride	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Nystatin	Nystatin	19	13
Trulicity	Dulaglutide	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Humalog Kwikpen U-200	Insulin Lispro	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Cimetidine	Cimetidine	14	suppressed
Levofloxacin	Levofloxacin	14	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Risperidone	Risperidone	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Temazepam	Temazepam	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Cefdinir	Cefdinir	13	13
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Lactulose	Lactulose	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Oxaprozin	Oxaprozin	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Junel Fe	Norethindrone-E.Estradiol-Iron	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error